Sony Salzman

Most Recent Articles by Sony Salzman

Orphan drugs leveraging new tech promise to cure disease

Orphan drugs leveraging new tech promise to cure disease

By

Two late-stage orphan drugs are upping the ante with their promise to cure disease.

Two drugs in the pipeline representing unique marketing challenges

Two drugs in the pipeline representing unique marketing challenges

By

Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.

High-profile candidates challenge marketers well in advance of launch

High-profile candidates challenge marketers well in advance of launch

By

With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.

The 2018 pipeline report: Aspiring assets to keep an eye on

The 2018 pipeline report: Aspiring assets to keep an eye on

By

The most promising products in pharma's pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.